BIIB vs EXEL
Biogen Inc. and Exelixis, Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | BIIB | EXEL |
|---|---|---|
| Revenue | $9.9B | $2.3B |
| Net income | $1.3B | $782.6M |
| Gross margin | 75.7% | 96.4% |
| Net margin | 13.1% | 33.7% |
| Return on equity | 7.4% | 35.5% |
| Diluted EPS | $8.79 | $2.78 |
| Dividend / share | · | · |
| Payout ratio | · | · |
| Free cash flow | $2.1B | $875.8M |
| Equity | · | $2.2B |
| Net debt / equity | 0.18× | · |
| Current ratio | 2.68× | 3.56× |
| Revenue CAGR 5y | −6.0% | 18.6% |
| Profit CAGR 5y | −20.2% | 47.6% |
BIIB bills 4.3× the revenue of EXEL, and EXEL keeps more of each dollar of revenue as profit (33.7% against 13.1%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | BIIB | EXEL |
|---|---|---|
| FY2025 | $9.9B | $2.3B |
| FY2024 | $9.7B | $2.2B |
| FY2023 | $9.8B | $1.8B |
| FY2022 | $10.2B | $1.6B |
| FY2021 | $11.0B | $1.4B |
| FY2020 | $13.4B | $987.5M |
| FY2019 | $14.4B | $967.8M |
| FY2018 | $13.5B | $853.8M |
| FY2017 | $12.3B | $452.5M |
| FY2016 | $11.4B | $191.5M |
Bottom line
| Fiscal year | BIIB | EXEL |
|---|---|---|
| FY2025 | $1.3B | $782.6M |
| FY2024 | $1.6B | $521.3M |
| FY2023 | $1.2B | $207.8M |
| FY2022 | $3.0B | $182.3M |
| FY2021 | $1.6B | $231.1M |
| FY2020 | $4.0B | $111.8M |
| FY2019 | $5.9B | $321.0M |
| FY2018 | $4.4B | $690.1M |
| FY2017 | $2.5B | $154.2M |
| FY2016 | $3.7B | $-70.2M |
17 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +$7,570,474,000 | BIIB |
| FY2024 | +$7,507,199,000 | BIIB |
| FY2023 | +$8,005,392,000 | BIIB |
| FY2022 | +$8,562,338,000 | BIIB |
| FY2021 | +$9,546,730,000 | BIIB |
| FY2020 | +$12,457,062,000 | BIIB |
| FY2019 | +$13,410,125,000 | BIIB |
| FY2018 | +$12,599,074,000 | BIIB |
| FY2017 | +$11,821,423,000 | BIIB |
| FY2016 | +$11,257,346,000 | BIIB |
| FY2015 | +$10,726,628,000 | BIIB |
| FY2014 | +$9,678,189,000 | BIIB |
| FY2013 | +$6,900,862,000 | BIIB |
| FY2012 | +$5,469,011,000 | BIIB |
| FY2011 | +$4,758,998,000 | BIIB |
| FY2010 | +$4,531,378,000 | BIIB |
| FY2009 | +$4,225,589,000 | BIIB |
BIIB has reported the higher revenue in every one of these 17 fiscal years. The gap has widened since the earliest year compared.
17 of 19 comparable fiscal years — a year missing data on either side is not counted.
17 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −20.7 pp | EXEL |
| FY2024 | −7.2 pp | EXEL |
| FY2023 | +0.5 pp | BIIB |
| FY2022 | +17.8 pp | BIIB |
| FY2021 | −0.4 pp | EXEL |
| FY2020 | +18.9 pp | BIIB |
| FY2019 | +7.8 pp | BIIB |
| FY2018 | −47.6 pp | EXEL |
| FY2017 | −12.3 pp | EXEL |
| FY2016 | +69.0 pp | BIIB |
| FY2015 | +468.5 pp | BIIB |
| FY2014 | +1070.9 pp | BIIB |
| FY2013 | +786.9 pp | BIIB |
| FY2012 | +331.3 pp | BIIB |
| FY2011 | −1.0 pp | EXEL |
| FY2010 | +68.9 pp | BIIB |
| FY2009 | +111.4 pp | BIIB |
The higher net margin has changed hands between BIIB and EXEL over this period.
17 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
EXEL's net margin has been more volatile than BIIB's over the 17 comparable fiscal years — 308.5 percentage points of standard deviation against 7.8.
17 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between BIIB and EXEL over these 17 fiscal years — BIIB led in 11 and EXEL in 6.
17 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
EXEL's return on equity has been more volatile than BIIB's over the 11 comparable fiscal years — 74.1 percentage points of standard deviation against 11.3.
11 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between BIIB and EXEL over these 11 fiscal years — BIIB led in 6 and EXEL in 5.
11 of 19 comparable fiscal years — a year missing data on either side is not counted.